Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20850576 | 0.81 | ALDH1A1 (0.47) | SMN1; SMN2RAB9AKMT2AMEN1NPC1 | |
| SCHEMBL12674550 | 0.81 | KMT2A (0.55) | MAPTSMN1; SMN2RAB9AKMT2AMEN1 | |
| SCHEMBL9911525 | 0.81 | KMT2A (0.59) | L3MBTL1KMT2AALDH1A1LMNACYP1A2 | |
| SCHEMBL19287247 | 0.80 | MEP1B (0.52) | KMT2AMEN1HDAC6PRKD1HDAC3 | |
| SCHEMBL12667380 | 0.80 | ALDH1A1 (0.46) | MAPTSMN1; SMN2RAB9AKMT2AMEN1 | |
| SCHEMBL18602021 | 0.79 | MAPT (0.50) | MAPTSMN1; SMN2L3MBTL1RAB9AKMT2A | |
| SCHEMBL18972056 | 0.79 | MEN1 (0.51) | MAPTSMN1; SMN2RAB9AKMT2AMEN1 | |
| SCHEMBL3114984 | 0.79 | LOXL2 (0.58) | MAPTRAB9AKMT2AMEN1NPC1 | |
| SCHEMBL3271284 | 0.78 | SIGMAR1 (0.48) | SMN1; SMN2ALDH1A1LMNACYP1A2ALOX15 | |
| SCHEMBL24239461 | 0.77 | ALDH1A1 (0.44) | SMN1; SMN2RAB9AKMT2AMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190209702-A1 | STEROIDS AND ANTIBODY-CONJUGATES THEREOF | REGENERON PHARMACEUTICALS, INC. | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190209702-A1 | STEROIDS AND ANTIBODY-CONJUGATES THEREOF | SERPINA6, NR3C1, NR3C2 | MAPT 2910/4885SMN1; SMN2 3669/4885L3MBTL1 2958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.